Navigation Links
AmkaiCharts

ProductsAmkaiCharts
Company Amkai, Inc.
Item AmkaiCharts
Features 
  • Integrated electrocardiogram and other digitally available instrument input.
  • Unique, proprietary image handling, including X-rays and other diagnostic images.
  • Integrated transcription; physicians can have their transcripted dictation within their electronic medical record. This is a very important feature to physicians in general and radiologists in particular. A radiologist's cash flow is largely dependent upon quickly processing their observations into a report. A streamlined transcription function within our electronic medical record accommodates this need.
  • Wireless, touch screen capability for point of care use.
  • Designed for the intranet, Internet, and available in an application service provider (ASP) mode.
  • Proprietary algorithm that seamlessly accommodates the needs of various medical disciplines through customized input/output screens.
  • Solid developer documentation supporting the changes and reducing possible adverse effects of an audit.
Description AmkaiCharts, is a state-of-the-art electronic medical record the development of which began in early 1998. It is a proven, comprehensive electronic medical record designed to be used by ambulatory healthcare providers at the point of care and to be shared selectively via an intranet and/or through the Internet. AmkaiCharts chronicles patient history, encounters, medication orders, procedures, referrals and vital statistics as well as collecting and storing data such as immunization records, X-rays, lab results and doctors notes.
Info Amkai, Inc.
Customer Service: (866) 265-2434
Web site: http://www.amkai.net

Related medicine products :

1. VersaSuite EHR
DErrico Perforator Drill and Enlarging Burr
Cushing Perforator Drill
Doro J-Arm Retractor System
Spoon End Periosteal
Medicine Products:
(Date:11/28/2009)...recognize signs of depression , , SATURD...the holiday season can trigger melancholy as they ...issues or worry about money problems, according to...rcome the seasonal blues, the AGS Foundation for H...t out and socialize or invite family and friends o...
(Date:11/27/2009)...wire-FirstCall/ -- The Gymboree Corporation (Nasda...will present at the NASDAQ OMX 23rd Investor Progr...ndon, England, on Wednesday, December 2, 2009, at ...t of The Gymboree Corporation,s presentation over ...lick on "Our Company" at the bottom of the page, g...
(Date:11/27/2009)...icles may reduce future disease burden, researcher...s) -- Encouraging city dwellers to walk and bicycl...ublic health benefits than increased used of low-e..., The study compared the projected health effects ...ios for London, England, and Delhi, India: busine...
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009)...olybdate (TM) has been shown in studies to be effe...e caused by an overload of copper, and certain met...however, is known about how the drug works at the ...rn University researchers now has provided an inva... bound to copper-loaded metallochaperones. The dru...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
..., Dec. 3, 2008 Joined by actress Maggie,Gyllenhaa...tionwide search for,five child Holiday Ambassadors...an event in New York City. The Duracell Holiday A...spread the joy of powering,up a gift for the first...
...., Dec. 3 Decision Resources, one of the,world,s ...armaceutical and,healthcare issues, finds that the...se in China is extremely low and will remain low t...eimer,s disease,population in China in 2012, less ...
... NextAdvisor.com has created a free g...ch to dieting. , San Fran....com , the trusted, independent source for compari...useful advice for those embarking on a new diet pl...
... Around 80 HBA, MBF and Mutual Commun...ir feet where their mouths were on Sunday to promo... charity in the inaugural HBA Great Australian Run... put their feet where their mouths were on Sunday ...
...Dec. 3 AGA Medical Corporation announced,today th...enne) approval for,its AMPLATZER(R) Cardiac Plug (...vasive solution for closing cardiac structures not...t addition to the interventional tools we have for...
...ec. 3, 2008 Scientists at UT Southwestern Medical...tein interferon plays a key role in "teaching" the...s of the same virus. , The findings, available on...therapies. , Typically, when a person is infecte...
Other Medicine News:Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 2Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 3Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:NextAdvisor.com Launches "Lose the Weight this Year: A Common Sense Dieter's Guide" 2Health News:HBA People Walk the Talk for Better Health in the HBA Great Australian Run 2Health News:AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug 2Health News:Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report 2
(Date:11/25/2009)... 25 Cempra Pharmaceuticals Inc. to...t and chief executive officer, will present at the...at 8:50 a.m. EST, December 1, 2009, at The New Yor...ll provide an overview of the company,s two leadin...f drug-resistant pathogens including MRSA. ,, ...
(Date:11/25/2009)...25 ChemoCentryx, Inc., announced...mpany,s PROTECT-1 (the Prospective Randomized Oral...raficet-EN(TM) (CCX282-B) in patients with moderat...efficacy with a favorable safety and tolerability ...cal efficacy in the reduction of disease severity ...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Vermillion, Inc. (VRML) (P... Plan of Reorganization and Disclosure Statement t...nkruptcy Court for the District of Delaware. A hea...ent is presently scheduled for December 8, 2009, w...heduled for January 7, 2010. ,, The Plan calls...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3